ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 64 filers reported holding ADURO BIOTECH INC in Q3 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -25.0% | 1,360 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 1,360 | -9.3% | 0.00% | – |
| Q2 2019 | $2,000 | -66.7% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 1,500 | +188.5% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 520 | -27.8% | 0.00% | – |
| Q2 2018 | $5,000 | -28.6% | 720 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -96.2% | 720 | -97.1% | 0.00% | -100.0% |
| Q4 2017 | $183,000 | +1563.6% | 24,420 | +2294.1% | 0.00% | – |
| Q3 2017 | $11,000 | -8.3% | 1,020 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | +300.0% | 1,020 | +218.8% | 0.00% | – |
| Q1 2017 | $3,000 | -57.1% | 320 | -46.7% | 0.00% | – |
| Q4 2016 | $7,000 | -74.1% | 600 | -72.7% | 0.00% | – |
| Q3 2016 | $27,000 | +8.0% | 2,200 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |